Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Depression: Overview01:18

Depression: Overview

228
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
228
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

117.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
117.1K
Long-term Depression01:03

Long-term Depression

2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.5K
Structure of Lipids03:38

Structure of Lipids

87.4K
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...
87.4K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

335
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
335

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Probiotic-Plant Bioactive Synergy in Gut Health: Mechanisms, Antimicrobial Activity, and Translational Challenges.

Nutrients·2026
Same author

Vitamin D as a Lifespan Neuroimmune Signal in Psychiatry: From Developmental Risk to Precision Nutrition.

Nutrients·2026
Same author

Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification.

International journal of molecular sciences·2026
Same author

The Regulatory Role of FABP4 in Microbiome-Brain-Gut Communication Under High-Fat-Diet Conditions.

International journal of molecular sciences·2026
Same author

Natural Bioactive Compounds Targeting FABP4 in Adipogenesis and Obesity: Evidence from In Vitro and In Vivo Studies.

International journal of molecular sciences·2026
Same author

The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 14, 2025

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

8.9K

Omega-3 Polyunsaturated Fatty Acids in Depression.

Anna Serefko1, Monika Elżbieta Jach2, Marlena Pietraszuk3

  • 1Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Lublin, Chodźki Street 7, 20-093 Lublin, Poland.

International Journal of Molecular Sciences
|August 29, 2024
PubMed
Summary

Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), show antidepressant potential by influencing brain health. However, research results are inconsistent, requiring further study for standardized use in depression management.

Keywords:
alpha-linolenic aciddepressiondocosahexaenoic acid (DHA)eicosapentaenoic acid (EPA)omega-3polyunsaturated fatty acids

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.4K

Related Experiment Videos

Last Updated: Jun 14, 2025

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

8.9K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.2K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.4K

Area of Science:

  • Neuroscience
  • Nutritional Psychiatry
  • Mental Health Research

Background:

  • Omega-3 polyunsaturated fatty acids (PUFAs) are increasingly investigated for their role in mental health, particularly depression.
  • Evidence suggests omega-3s, specifically EPA and DHA, may possess antidepressant properties.
  • These effects are linked to modulation of neuroinflammation, neurotransmitter function, and neuroplasticity.

Purpose of the Study:

  • To review current research on the efficacy of omega-3 fatty acids in preventing and treating depressive disorders.
  • To explore the mechanisms underlying the potential antidepressant effects of omega-3s.
  • To identify factors contributing to inconsistent clinical trial outcomes and highlight areas for future research.

Main Methods:

  • Systematic review of existing scientific literature on omega-3 fatty acids and depression.
  • Analysis of studies examining the impact of omega-3 supplementation on depressive symptoms.
  • Evaluation of factors such as dosage, EPA/DHA ratio, and baseline nutritional status on treatment outcomes.

Main Results:

  • Clinical trials on omega-3 supplementation for depression have yielded mixed results, with some showing significant symptom reduction and others minimal benefit.
  • Potential benefits are attributed to omega-3s' influence on neuroinflammation, neurotransmitter systems, and neuroplasticity.
  • Omega-3s may serve as an adjunctive therapy for individuals undergoing conventional antidepressant treatment.

Conclusions:

  • While omega-3 fatty acids show promise for depression management, inconsistent findings necessitate further research.
  • Variability in study designs and individual responses highlights the need for standardized guidelines.
  • Future research should focus on optimizing dosage, EPA/DHA ratios, and patient selection for omega-3 supplementation in treating depressive disorders.